Left ventricular assist device

A left ventricular assist device (LVAD) is a pump that helps the left ventricle move blood. MeSH describes heart-assist pumps as small, often implantable, with a pumping chamber and a power source that may sit partly or fully outside the body. In the United States the HeartMate 3 system holds premarket approval P160054. Its approval orders state an indication for short-term support (2017) and later for short- and long-term support, including destination therapy (2018), in advanced refractory left ventricular heart failure.

Also called LVAD · Left ventricular assist system

  • Technology
  • In this atlas

Overview

Technical summary

MeSH descriptor D006353 (Heart-Assist Devices) is a broad match: its scope note says the pumps are for temporarily assisting the heart, which is narrower than durable LVAD support in time, and wider in device type. FDA product code DSQ (Ventricular (Assist) Bypass), class 3, is a broad match: its name does not limit it to the left ventricle or to one system, and the openFDA classification record is read only for its name and class. The approval facts are for one device family, HeartMate 3 (premarket approval P160054; original order 2017-08-23, supplement S008 2018-10-18). The registry entry for MOMENTUM 3 is filed on the implantation page.

How it works

A left ventricular assist device is a pump that helps the left ventricle move blood. MeSH describes heart-assist pumps as having a pumping chamber and a power source, which may be partly or fully outside the body.

Classification codes

  • MeSH MeSH linked-data descriptor D006353, read 2026-11-08; the descriptor covers temporary assist devices D006353
  • FDA product code openFDA device classification endpoint, retrieved 2026-11-08 DSQ Ventricular (Assist) Bypass

Limitations

  • The sources read here are two FDA approval orders and a registry entry; they state indications and a study design, and no result is recorded on this page.
  • The approval facts cover one device family only.

Required infrastructure

  • The MeSH scope note says the power source may be partially or totally external to the body.

Claims and evidence

Context Patients for whom the US approval orders of the HeartMate 3 Left Ventricular Assist System state an indication: advanced refractory left ventricular heart failure

Recipient
Recipient not specified
Population
Patients with advanced refractory left ventricular heart failure, as the approval order statements describe them. The statements read here do not name an age group.
Care setting
Implanted left ventricular assist system
Geography
United States (premarket approval of the US Food and Drug Administration)
Life stage
Not stated in the statements read
Gestational age
Not reported
Postnatal age
Not reported
Follow-up
Not applicable (regulatory statement)
Eligibility: 1 inclusion criterion; exclusion criteria not stated
Included
  • Patients with advanced refractory left ventricular heart failure
Excluded
None stated
  • Description Evidence stage not applicable Certainty not assessed

    The openFDA record of premarket approval P160054 (Abbott Medical) lists approval of the HeartMate 3 Left Ventricular Assist System on 23 August 2017 under product code DSQ. The approval order states the indication as short-term hemodynamic support, such as bridge to transplant or bridge to myocardial recovery, in patients with advanced refractory left ventricular heart failure. Supplement S008, approved on 18 October 2018, states the indication as short- and long-term mechanical circulatory support, such as bridge to transplant or myocardial recovery, or destination therapy, in the same patients.

    Applies to Recipient not specified Patients for whom the US approval orders of the HeartMate 3 Left Ventricular Assist System state an indication: advanced refractory left ventricular heart failure

    Certainty method
    Not assessed
    Limitations
    This claim covers one device family, the HeartMate 3 system approved under P160054 (product code DSQ). It does not cover other implantable pumps. Only two of the 133 openFDA records for P160054 are read, and later supplements may change the wording. A search listing also showed a 2020 labeling update on pediatric uses and a 2022 update to the instructions for use; neither was read. An FDA approval is a decision about a device, not a finding about how well it works. openFDA says its data are unvalidated and not to be relied on for decisions about medical care.
    Last checked
    2026-11-08
    Next evidence check due
    Not scheduled
    Sources and citations (12)
    1. Supports FDA premarket approval P160054: HeartMate 3 Left Ventricular Assist System (openFDA records of the original approval and supplement S008)

      Regulator · U.S. Food and Drug Administration (openFDA) · Edition The openFDA PMA record of the original approval of P160054 (decision date 2017-08-23) and the record of supplement S008 (decision date 2018-10-18), both returned on 2026-11-08. P160054 has 133 PMA records in openFDA; only these two are read. · PMA: P160054

      Locator
      results[0].pma_number
      How it applies
      Quoted at this locator.
      Retrieved
      Source effective date
      2017-08-23
      Source state
      Current
      Version fingerprint
      51f42e65de3cb94f8b7cbf4ae55486fe4f6ef3315b1d79a24a21ac26344f0a60
      Reuse basis
      openFDA data is public domain under a Creative Commons CC0 1.0 Universal dedication (https://open.fda.gov/terms/ and https://open.fda.gov/license/). The raw records are committed in the atlas repository. They include contact, address and registration fields that FDA publishes; records here do not repeat them.
    2. Supports FDA premarket approval P160054: HeartMate 3 Left Ventricular Assist System (openFDA records of the original approval and supplement S008)

      Regulator · U.S. Food and Drug Administration (openFDA) · Edition The openFDA PMA record of the original approval of P160054 (decision date 2017-08-23) and the record of supplement S008 (decision date 2018-10-18), both returned on 2026-11-08. P160054 has 133 PMA records in openFDA; only these two are read. · PMA: P160054

      Locator
      results[0].applicant
      How it applies
      Quoted at this locator.
      Retrieved
      Source effective date
      2017-08-23
      Source state
      Current
      Version fingerprint
      51f42e65de3cb94f8b7cbf4ae55486fe4f6ef3315b1d79a24a21ac26344f0a60
      Reuse basis
      openFDA data is public domain under a Creative Commons CC0 1.0 Universal dedication (https://open.fda.gov/terms/ and https://open.fda.gov/license/). The raw records are committed in the atlas repository. They include contact, address and registration fields that FDA publishes; records here do not repeat them.
    3. Supports FDA premarket approval P160054: HeartMate 3 Left Ventricular Assist System (openFDA records of the original approval and supplement S008)

      Regulator · U.S. Food and Drug Administration (openFDA) · Edition The openFDA PMA record of the original approval of P160054 (decision date 2017-08-23) and the record of supplement S008 (decision date 2018-10-18), both returned on 2026-11-08. P160054 has 133 PMA records in openFDA; only these two are read. · PMA: P160054

      Locator
      results[0].trade_name
      How it applies
      Quoted at this locator.
      Retrieved
      Source effective date
      2017-08-23
      Source state
      Current
      Version fingerprint
      51f42e65de3cb94f8b7cbf4ae55486fe4f6ef3315b1d79a24a21ac26344f0a60
      Reuse basis
      openFDA data is public domain under a Creative Commons CC0 1.0 Universal dedication (https://open.fda.gov/terms/ and https://open.fda.gov/license/). The raw records are committed in the atlas repository. They include contact, address and registration fields that FDA publishes; records here do not repeat them.
    4. Supports FDA premarket approval P160054: HeartMate 3 Left Ventricular Assist System (openFDA records of the original approval and supplement S008)

      Regulator · U.S. Food and Drug Administration (openFDA) · Edition The openFDA PMA record of the original approval of P160054 (decision date 2017-08-23) and the record of supplement S008 (decision date 2018-10-18), both returned on 2026-11-08. P160054 has 133 PMA records in openFDA; only these two are read. · PMA: P160054

      Locator
      results[0].decision_date
      How it applies
      Quoted at this locator.
      Retrieved
      Source effective date
      2017-08-23
      Source state
      Current
      Version fingerprint
      51f42e65de3cb94f8b7cbf4ae55486fe4f6ef3315b1d79a24a21ac26344f0a60
      Reuse basis
      openFDA data is public domain under a Creative Commons CC0 1.0 Universal dedication (https://open.fda.gov/terms/ and https://open.fda.gov/license/). The raw records are committed in the atlas repository. They include contact, address and registration fields that FDA publishes; records here do not repeat them.
    5. Supports FDA premarket approval P160054: HeartMate 3 Left Ventricular Assist System (openFDA records of the original approval and supplement S008)

      Regulator · U.S. Food and Drug Administration (openFDA) · Edition The openFDA PMA record of the original approval of P160054 (decision date 2017-08-23) and the record of supplement S008 (decision date 2018-10-18), both returned on 2026-11-08. P160054 has 133 PMA records in openFDA; only these two are read. · PMA: P160054

      Locator
      results[0].decision_code
      How it applies
      Quoted at this locator.
      Retrieved
      Source effective date
      2017-08-23
      Source state
      Current
      Version fingerprint
      51f42e65de3cb94f8b7cbf4ae55486fe4f6ef3315b1d79a24a21ac26344f0a60
      Reuse basis
      openFDA data is public domain under a Creative Commons CC0 1.0 Universal dedication (https://open.fda.gov/terms/ and https://open.fda.gov/license/). The raw records are committed in the atlas repository. They include contact, address and registration fields that FDA publishes; records here do not repeat them.
    6. Supports FDA premarket approval P160054: HeartMate 3 Left Ventricular Assist System (openFDA records of the original approval and supplement S008)

      Regulator · U.S. Food and Drug Administration (openFDA) · Edition The openFDA PMA record of the original approval of P160054 (decision date 2017-08-23) and the record of supplement S008 (decision date 2018-10-18), both returned on 2026-11-08. P160054 has 133 PMA records in openFDA; only these two are read. · PMA: P160054

      Locator
      results[0].product_code
      How it applies
      Quoted at this locator.
      Retrieved
      Source effective date
      2017-08-23
      Source state
      Current
      Version fingerprint
      51f42e65de3cb94f8b7cbf4ae55486fe4f6ef3315b1d79a24a21ac26344f0a60
      Reuse basis
      openFDA data is public domain under a Creative Commons CC0 1.0 Universal dedication (https://open.fda.gov/terms/ and https://open.fda.gov/license/). The raw records are committed in the atlas repository. They include contact, address and registration fields that FDA publishes; records here do not repeat them.
    7. Supports FDA premarket approval P160054: HeartMate 3 Left Ventricular Assist System (openFDA records of the original approval and supplement S008)

      Regulator · U.S. Food and Drug Administration (openFDA) · Edition The openFDA PMA record of the original approval of P160054 (decision date 2017-08-23) and the record of supplement S008 (decision date 2018-10-18), both returned on 2026-11-08. P160054 has 133 PMA records in openFDA; only these two are read. · PMA: P160054

      Locator
      results[0].ao_statement, fragment 1 of 2
      How it applies
      Quoted at this locator.
      Retrieved
      Source effective date
      2017-08-23
      Source state
      Current
      Version fingerprint
      51f42e65de3cb94f8b7cbf4ae55486fe4f6ef3315b1d79a24a21ac26344f0a60
      Reuse basis
      openFDA data is public domain under a Creative Commons CC0 1.0 Universal dedication (https://open.fda.gov/terms/ and https://open.fda.gov/license/). The raw records are committed in the atlas repository. They include contact, address and registration fields that FDA publishes; records here do not repeat them.
    8. Supports FDA premarket approval P160054: HeartMate 3 Left Ventricular Assist System (openFDA records of the original approval and supplement S008)

      Regulator · U.S. Food and Drug Administration (openFDA) · Edition The openFDA PMA record of the original approval of P160054 (decision date 2017-08-23) and the record of supplement S008 (decision date 2018-10-18), both returned on 2026-11-08. P160054 has 133 PMA records in openFDA; only these two are read. · PMA: P160054

      Locator
      results[0].ao_statement, fragment 2 of 2
      How it applies
      Quoted at this locator.
      Retrieved
      Source effective date
      2017-08-23
      Source state
      Current
      Version fingerprint
      51f42e65de3cb94f8b7cbf4ae55486fe4f6ef3315b1d79a24a21ac26344f0a60
      Reuse basis
      openFDA data is public domain under a Creative Commons CC0 1.0 Universal dedication (https://open.fda.gov/terms/ and https://open.fda.gov/license/). The raw records are committed in the atlas repository. They include contact, address and registration fields that FDA publishes; records here do not repeat them.
    9. Supports FDA premarket approval P160054: HeartMate 3 Left Ventricular Assist System (openFDA records of the original approval and supplement S008)

      Regulator · U.S. Food and Drug Administration (openFDA) · Edition The openFDA PMA record of the original approval of P160054 (decision date 2017-08-23) and the record of supplement S008 (decision date 2018-10-18), both returned on 2026-11-08. P160054 has 133 PMA records in openFDA; only these two are read. · PMA: P160054

      Locator
      results[0].supplement_number
      How it applies
      Quoted at this locator.
      Retrieved
      Source effective date
      2018-10-18
      Source state
      Current
      Version fingerprint
      76e473079df9a05275390fde81870ba2bce782dddc37138185651f8ca6c1792b
      Reuse basis
      openFDA data is public domain under a Creative Commons CC0 1.0 Universal dedication (https://open.fda.gov/terms/ and https://open.fda.gov/license/). The raw records are committed in the atlas repository. They include contact, address and registration fields that FDA publishes; records here do not repeat them.
    10. Supports FDA premarket approval P160054: HeartMate 3 Left Ventricular Assist System (openFDA records of the original approval and supplement S008)

      Regulator · U.S. Food and Drug Administration (openFDA) · Edition The openFDA PMA record of the original approval of P160054 (decision date 2017-08-23) and the record of supplement S008 (decision date 2018-10-18), both returned on 2026-11-08. P160054 has 133 PMA records in openFDA; only these two are read. · PMA: P160054

      Locator
      results[0].decision_date
      How it applies
      Quoted at this locator.
      Retrieved
      Source effective date
      2018-10-18
      Source state
      Current
      Version fingerprint
      76e473079df9a05275390fde81870ba2bce782dddc37138185651f8ca6c1792b
      Reuse basis
      openFDA data is public domain under a Creative Commons CC0 1.0 Universal dedication (https://open.fda.gov/terms/ and https://open.fda.gov/license/). The raw records are committed in the atlas repository. They include contact, address and registration fields that FDA publishes; records here do not repeat them.
    11. Supports FDA premarket approval P160054: HeartMate 3 Left Ventricular Assist System (openFDA records of the original approval and supplement S008)

      Regulator · U.S. Food and Drug Administration (openFDA) · Edition The openFDA PMA record of the original approval of P160054 (decision date 2017-08-23) and the record of supplement S008 (decision date 2018-10-18), both returned on 2026-11-08. P160054 has 133 PMA records in openFDA; only these two are read. · PMA: P160054

      Locator
      results[0].ao_statement, fragment 1 of 2
      How it applies
      Quoted at this locator.
      Retrieved
      Source effective date
      2018-10-18
      Source state
      Current
      Version fingerprint
      76e473079df9a05275390fde81870ba2bce782dddc37138185651f8ca6c1792b
      Reuse basis
      openFDA data is public domain under a Creative Commons CC0 1.0 Universal dedication (https://open.fda.gov/terms/ and https://open.fda.gov/license/). The raw records are committed in the atlas repository. They include contact, address and registration fields that FDA publishes; records here do not repeat them.
    12. Supports FDA premarket approval P160054: HeartMate 3 Left Ventricular Assist System (openFDA records of the original approval and supplement S008)

      Regulator · U.S. Food and Drug Administration (openFDA) · Edition The openFDA PMA record of the original approval of P160054 (decision date 2017-08-23) and the record of supplement S008 (decision date 2018-10-18), both returned on 2026-11-08. P160054 has 133 PMA records in openFDA; only these two are read. · PMA: P160054

      Locator
      results[0].ao_statement, fragment 2 of 2
      How it applies
      Quoted at this locator.
      Retrieved
      Source effective date
      2018-10-18
      Source state
      Current
      Version fingerprint
      76e473079df9a05275390fde81870ba2bce782dddc37138185651f8ca6c1792b
      Reuse basis
      openFDA data is public domain under a Creative Commons CC0 1.0 Universal dedication (https://open.fda.gov/terms/ and https://open.fda.gov/license/). The raw records are committed in the atlas repository. They include contact, address and registration fields that FDA publishes; records here do not repeat them.

Clinical links

Each link reports what one cited claim says about one population. "Evaluated for" means studied, not shown to work. These links do not show that anything is effective or right for you.

Record details

Record id
cardio:left-ventricular-assist-device
Content hash
05cb18dd5f8a5e0541641e133f1972530d26032820610acb8d0470d6c9eb06e8